Mindset Pharma Inc.
MSSTF · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -24.5% | 45.4% | 4.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -155.4% | -83.1% | -29.5% | -33.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -156% | -83.5% | -30.1% | -34% |
| EPS Diluted | -0.03 | -0.022 | -0.006 | -0.006 |
| % Growth | -35.6% | -298.2% | 11.3% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |